7 listopada 2018

Annual Meeting u0026 Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC), 7-11 November 2018, Washington, DC, USA

Rok

2018

Cel

STING, A2A/A2B

Zasoby na tej stronie

Pobierz zasoby

  • plik pdf

    "Novel class of small molecule direct STING agonists as a potential cancer immunotherapy"

    Pobierz
  • plik pdf

    “Characterization of novel dual A2A/B adenosine receptor antagonists for cancer immunotherapy”

    Pobierz